Structure Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GPCR and other ETFs, options, and stocks.About GPCR
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578.
CEORaymond C. Stevens
CEORaymond C. Stevens
Employees163
Employees163
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2016
Founded2016
Employees163
Employees163
GPCR Key Statistics
Market cap4.21B
Market cap4.21B
Price-Earnings ratio-9.46
Price-Earnings ratio-9.46
Dividend yield—
Dividend yield—
Average volume985.50K
Average volume985.50K
High today$94.90
High today$94.90
Low today$23.26
Low today$23.26
Open price$45.17
Open price$45.17
Volume14.83M
Volume14.83M
52 Week high$94.90
52 Week high$94.90
52 Week low$13.22
52 Week low$13.22
Stock Snapshot
The current Structure Therapeutics(GPCR) stock price is $69.39, with a market capitalization of 4.21B. The stock trades at a price-to-earnings (P/E) ratio of -9.46.
On 2025-12-08, Structure Therapeutics(GPCR) stock moved within a range of $23.26 to $94.90. With shares now at $69.39, the stock is trading +198.3% above its intraday low and -26.9% below the session's peak.
Trading activity shows a volume of 14.83M, compared to an average daily volume of 985.5K.
The stock's 52-week range extends from a low of $13.22 to a high of $94.90.
The stock's 52-week range extends from a low of $13.22 to a high of $94.90.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%